SMS Lifesciences India's Stock Price Reaches All-Time High, Outperforms Sector

Sep 04 2024 12:35 PM IST
share
Share Via
SMS Lifesciences India, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high of Rs. 1519 on September 4th, 2024. The stock has outperformed the sector by 3.54% and has been on a consecutive gain streak for the past 2 days. It is currently trading above its moving averages and has shown a 191.77% increase in the past year, making it a promising investment option in the pharma industry.

SMS Lifesciences India, a microcap pharmaceutical company, has been making waves in the stock market with its recent surge in stock price. On September 4th, 2024, the company's stock price reached a 52-week high of Rs. 1519, which is also an all-time high for the company. This has caught the attention of investors and analysts alike, with MarketsMOJO giving a 'Hold' call for the stock.

The stock has been performing exceptionally well, outperforming the sector by 3.54% on the day of the 52-week high. It has also been on a consecutive gain streak for the past 2 days, with a 8.22% increase in returns during this period. The intraday high for the stock was Rs. 1519, a 4.35% increase from the previous day's closing price.

In addition, SMS Lifesciences is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the stock's performance. This is a promising sign for investors and shows the company's strong financials and growth potential.

In comparison to the Sensex, SMS Lifesciences has shown an impressive 1-year performance of 191.77%, while the Sensex has only seen a 25.16% increase. This further highlights the company's strong performance and potential for growth in the pharmaceutical industry.

Overall, SMS Lifesciences India is a microcap company that has been gaining attention in the stock market with its recent surge in stock price. With a 'Hold' call from MarketsMOJO and a strong performance in the past year, the company shows promise for investors looking for potential growth in the pharma sector.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News